AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review
LE Targownik, DA Fisher, SD Saini - Gastroenterology, 2022 - Elsevier
Description Proton pump inhibitors (PPIs) are among the most commonly used medications
in the world. Developed for the treatment and prevention of acid-mediated upper …
in the world. Developed for the treatment and prevention of acid-mediated upper …
Evidence-based clinical practice guidelines for peptic ulcer disease 2020
T Kamada, K Satoh, T Itoh, M Ito, J Iwamoto… - Journal of …, 2021 - Springer
Abstract The Japanese Society of Gastroenterology (JSGE) revised the third edition of
evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an …
evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an …
Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report
P Malfertheiner, F Mégraud, CA O'Morain, JP Gisbert… - Gut, 2017 - gut.bmj.com
Important progress has been made in the management of Helicobacter pylori infection and
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …
in this fifth edition of the Maastricht Consensus Report, key aspects related to the clinical role …
The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association
DE Freedberg, LS Kim, YX Yang - Gastroenterology, 2017 - Elsevier
Background & Aims The purpose of this review is to evaluate the risks associated with long-
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …
Diagnosis and treatment of peptic ulcer disease
RT Kavitt, AM Lipowska, A Anyane-Yeboa… - The American journal of …, 2019 - Elsevier
Peptic ulcer disease continues to be a source of significant morbidity and mortality
worldwide. Approximately two-thirds of patients found to have peptic ulcer disease are …
worldwide. Approximately two-thirds of patients found to have peptic ulcer disease are …
[HTML][HTML] Non-steroidal anti-inflammatory drugs and the gastrointestinal tract
FWD Tai, ME McAlindon - Clinical Medicine, 2021 - Elsevier
Non-steroidal anti-inflammatory drugs (NSAIDs) are used commonly but can cause foregut
symptoms, peptic ulcer disease and small bowel enteropathy. Such iatrogenic injury can be …
symptoms, peptic ulcer disease and small bowel enteropathy. Such iatrogenic injury can be …
[HTML][HTML] A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the …
O Bruyère, C Cooper, JP Pelletier, E Maheu… - Seminars in arthritis and …, 2016 - Elsevier
Abstract The European Society for Clinical and Economic Aspects of Osteoporosis and
Osteoarthritis (ESCEO) published a treatment algorithm for the management of knee …
Osteoarthritis (ESCEO) published a treatment algorithm for the management of knee …
Management of patients with ulcer bleeding
L Laine, DM Jensen - Official journal of the American College of …, 2012 - journals.lww.com
This guideline presents recommendations for the step-wise management of patients with
overt upper gastrointestinal bleeding. Hemodynamic status is first assessed, and …
overt upper gastrointestinal bleeding. Hemodynamic status is first assessed, and …
Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации
АЕ Каратеев, ЕЛ Насонов… - Научно …, 2018 - rsp.mediar-press.net
Аннотация В 2015 г. экспертами, представляющими различные врачебные ассоциации
России, были разработаны клинические рекомендации «Рациональное применение …
России, были разработаны клинические рекомендации «Рациональное применение …
[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research …
W Zhang, G Nuki, RW Moskowitz, S Abramson… - Osteoarthritis and …, 2010 - Elsevier
OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 …
osteoarthritis (OA) and to examine whether research evidence has changed from 31 …